Back
BlackRock MuniYield New York Quality Fund Vs. Aligos Therapeutics, Inc. Industry Stock Comparison
Buy
63
MYN
BlackRock MuniYield New York Quality Fund
Last Price:
$10.08
Seasonality Move:
2.78%
Buy
82
ALGS
Aligos Therapeutics, Inc.
Last Price:
$13.24
Seasonality Move:
-2.85%
Buy
63
BlackRock MuniYield New York Quality Fund (MYN)
is a Buy
Is BlackRock MuniYield New York Quality Fund a Buy, Sell or Hold?
-
The current BlackRock MuniYield New York Quality Fund [MYN] share price is $10.08. The Score for MYN is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
MYN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
82
Aligos Therapeutics, Inc. (ALGS)
is a Buy
Is Aligos Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Aligos Therapeutics, Inc. [ALGS] share price is $13.30. The Score for ALGS is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
MYN Stock Price Chart
What is BlackRock MuniYield New York Quality Fund's stock price today?
-
The BlackRock MuniYield New York Quality Fund share price today is $10.08The current trend is relatively stagnant and MYN is experiencing slight selling pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics, Inc.'s stock price today?
-
The Aligos Therapeutics, Inc. share price today is $13.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
MYN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 51.21 | Buy |
| Chaikin Money Flow: | -18909 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.96 - 10.12) | Buy |
| Bollinger Bands (100): | (9.44 - 10.14) | Buy |
ALGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.91 | Buy |
| Relative Strength Index (14 RSI): | 81.16 | Buy |
| Chaikin Money Flow: | 127954 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.2 - 10.84) | Buy |
| Bollinger Bands (100): | (7.91 - 10.67) | Buy |
MYN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.13 | Sell |
| 20-day SMA: | 10.06 | Buy |
| 50-day SMA: | 10.08 | Sell |
| 200-day SMA: | 9.73 | Buy |
| 8-day EMA: | 10.1 | Sell |
| 20-day EMA: | 10.08 | Buy |
| 50-day EMA: | 9.81 | Buy |
| 200-day EMA: | 6.1 | Buy |
ALGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.99 | Buy |
| 20-day SMA: | 9.62 | Buy |
| 50-day SMA: | 9.17 | Buy |
| 200-day SMA: | 8.45 | Buy |
| 8-day EMA: | 11.23 | Buy |
| 20-day EMA: | 10.07 | Buy |
| 50-day EMA: | 9.41 | Buy |
| 200-day EMA: | 10.52 | Buy |
BlackRock MuniYield New York Quality Fund Earnings Growth & MYN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics, Inc. Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.41 per share, and a decrease next year of $0.26 per share.
BlackRock MuniYield New York Quality Fund Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aligos Therapeutics, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||